Skip to main content
Log in

Frequency Characterization of Blood Glucose Dynamics

  • Published:
Annals of Biomedical Engineering Aims and scope Submit manuscript

Abstract

Examples of the frequency range of blood glucose dynamics of normal subjects and subjects with diabetes are reported here, based on data from the literature. The frequency band edge was determined from suitable, frequently sampled blood glucose recordings using two methods: frequency domain estimation and signal reconstruction. The respective maximum acceptable sampling intervals, or Nyquist sampling periods (NSP), required to accurately represent blood glucose dynamics were calculated. Preliminary results based on the limited data available in the literature indicate that although blood glucose NSP values are higher in most diabetic subjects, values in some diabetic subjects are indistinguishable from those of normal subjects. High fidelity monitoring sufficient to follow the intrinsic blood glucose dynamics of all diabetic subjects requires a NSP of ~ 10 min, corresponding to a continuous frequency band edge of ~ 1 × 10−3 Hz. This analysis provides key information for the design of clinical studies that include blood glucose dynamics and for the design of new glucose monitoring systems. © 2003 Biomedical Engineering Society.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. Bremer, T., and D. A. Gough. Is blood glucose predictable from previous values? A solicitation for data. Diabetes48:445­451, 1999.­

    Google Scholar 

  2. Bremer, T. M., S. V. Edelman, and D. A. Gough. Benchmark data from the literature for evaluation of new glucose sensing technologies. Diabetes Tech., Therapeu.3:409­418, 2001.­

    Google Scholar 

  3. Gabbay, K. H., K. Hasty, J. L. Breslow, R. C. Ellison, H. F. Bunn, and P. M. Gallop. Glycosylated hemoglobins and long­term blood glucose control in diabetes mellitus. J. Clin. Endocrin., Metab.44:859­864, 1977.­

    Google Scholar 

  4. glucosecontrol.ucsd.edu­

  5. Molnar, G. D., E. Ackerman, J. W. Rosevear, L. C. Gatewood, and K. E. Moxness. Continuous blood glucose analysis in ambulatory fed subjects. I. General methodology. Mayo Clin. Proc.43:833­851, 1968.­

    Google Scholar 

  6. Ohno, M., K. Ito, S. Saito, S. Kageyama, Y. Ikeda, T. Tanese, and M. Abe. Clinical usefulness of artificial endocrine pancreas “Biostator” in management of unstable diabetics. Tohoku J. Exper. Med.141:723­732, 1983.­

    Google Scholar 

  7. Oppenheim, A. V., and R. W. Schafer. Discrete­Time Signal Processing. Englewood Cliffs, NJ: Prentice Hall, 1989.­

    Google Scholar 

  8. Pfeiffer, E. F., C. Meyerhoff, F. Bischof, F. S. Keck, and W. Kerner. On line continuous monitoring of subcutaneous tissue glucose is feasible by combining portable glucosensor with microdialysis. Horm. Metab. Res.25:121­124, 1993.­

    Google Scholar 

  9. Reichard, P., B.­Y. Nilsson, and U. Rosenqvist. The effect of long­term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N. Eng. J. Med.329:304­309, 1993.­

    Google Scholar 

  10. Santiago, J. V., W. L. Clarke, and F. Arias. Studies with a pancreatic beta cell simulator in the third trimester of pregnancies complicated by diabetes. Am. J. Obstet. Gynecol.132:455­463, 1978.­

    Google Scholar 

  11. Service, F. J., G. D. Molnar, J. W. Rosevear, E. Ackerman, W. F. Taylor, G. M. Cremer, and K. E. Moxness. Continuous blood glucose analysis in ambulatory fed subjects. II. Effects of anticoagulation with heparin. Mayo Clin. Proc.44:466­477, 1969.­

    Google Scholar 

  12. Service, F. J., G. D. Molnar, J. W. Rosevear, E. Ackerman, L. C. Gatewood, and W. F. Taylor. Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes19:644­655, 1970.­

    Google Scholar 

  13. Service, F. J., G. D. Molnar, and W. F. Taylor. Urine glucose analyses during continuous monitoring. J. Am. Med. Assoc.222:294­298, 1972.­

    Google Scholar 

  14. Slama, G., J. C. Klein, M. C. Tardieu, and G. Tchobroutsky. The normalization of blood sugar using a nonminiaturized artificial pancreas. Application for 24 h in seven insulin­dependent diabetics. Nouv. Presse Med.6:2309­2313, 1977.­

    Google Scholar 

  15. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long­term complications in insulin­dependent diabetes mellitus. N. Engl. J. Med.329:977­986, 1993.­

  16. United Kingdom Prospective Diabetes Study Group. Intensive blood­glucose control with sulfonylureas or insulin compared with conventional treatment and the risk of complications in patients with type 2 diabetes. Lancet352:837­853, 1998.­

  17. Zimmet, P., K. G. M. Alberti, and J. Shaw. Global and societal implications of the diabetes epidemic. Nature (London)414:782­787, 2001.­ ­

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gough, D.A., Kreutz-Delgado, K. & Bremer, T.M. Frequency Characterization of Blood Glucose Dynamics. Annals of Biomedical Engineering 31, 91–97 (2003). https://doi.org/10.1114/1.1535411

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1114/1.1535411

Navigation